Unimicron Technology Crescita futura
Future criteri di controllo 5/6
Unimicron Technology prevede che gli utili e i ricavi cresceranno rispettivamente di 62.5% e 19.7% all'anno. Si prevede che l'EPS crescerà di 58.4% all'anno. Si prevede che il ritorno sul capitale proprio sarà di 20.6% in 3 anni.
Informazioni chiave
62.5%
Tasso di crescita degli utili
58.4%
Tasso di crescita dell'EPS
| Electronic crescita degli utili | 24.3% |
| Tasso di crescita dei ricavi | 19.7% |
| Rendimento futuro del capitale proprio | 20.6% |
| Copertura analitica | Good |
| Ultimo aggiornamento | 21 Nov 2024 |
Aggiornamenti recenti sulla crescita futura
Unimicron Technology Corp. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Nov 01
Analysts Are Updating Their Unimicron Technology Corp. (TWSE:3037) Estimates After Its Second-Quarter Results
Aug 03Earnings Beat: Unimicron Technology Corp. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Apr 25Recent updates
Some Investors May Be Willing To Look Past Unimicron Technology's (TWSE:3037) Soft Earnings
Nov 08Why Investors Shouldn't Be Surprised By Unimicron Technology Corp.'s (TWSE:3037) 28% Share Price Surge
Nov 07Unimicron Technology Corp. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Nov 01At NT$149, Is It Time To Put Unimicron Technology Corp. (TWSE:3037) On Your Watch List?
Sep 29Does Unimicron Technology (TWSE:3037) Have A Healthy Balance Sheet?
Sep 12The Price Is Right For Unimicron Technology Corp. (TWSE:3037) Even After Diving 26%
Aug 17Analysts Are Updating Their Unimicron Technology Corp. (TWSE:3037) Estimates After Its Second-Quarter Results
Aug 03We Like These Underlying Return On Capital Trends At Unimicron Technology (TWSE:3037)
Jul 30Unimicron Technology's (TWSE:3037) Dividend Is Being Reduced To NT$3
Jun 20Unimicron Technology Corp.'s (TWSE:3037) Popularity With Investors Is Clear
Jun 12Earnings Beat: Unimicron Technology Corp. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Apr 25Why Unimicron Technology Corp. (TWSE:3037) Could Be Worth Watching
Apr 18Unimicron Technology (TWSE:3037) Seems To Use Debt Quite Sensibly
Apr 05Unimicron Technology Corp. (TWSE:3037) Released Earnings Last Week And Analysts Lifted Their Price Target To NT$220
Feb 29Unimicron Technology (TPE:3037) Seems To Use Debt Quite Sensibly
Apr 19Here's Why We Think Unimicron Technology (TPE:3037) Is Well Worth Watching
Apr 07Unimicron Technology (TPE:3037) Has Rewarded Shareholders With An Exceptional 494% Total Return On Their Investment
Mar 05Previsioni di crescita degli utili e dei ricavi
| Data | Ricavi | Guadagni | Flusso di cassa libero | Liquidità dell'operazione | Avg. Numero di analisti |
|---|---|---|---|---|---|
| 12/31/2026 | 170,758 | 29,292 | 28,457 | 47,964 | 9 |
| 12/31/2025 | 148,154 | 19,478 | 15,021 | 33,417 | 15 |
| 12/31/2024 | 117,750 | 7,358 | -4,773 | 17,682 | 12 |
| 9/30/2024 | 111,682 | 7,933 | -11,453 | 13,768 | N/A |
| 6/30/2024 | 106,515 | 9,525 | -5,656 | 19,501 | N/A |
| 3/31/2024 | 103,873 | 10,318 | -4,528 | 19,506 | N/A |
| 12/31/2023 | 104,036 | 11,980 | 7,962 | 30,900 | N/A |
| 9/30/2023 | 115,036 | 16,433 | 13,092 | 38,285 | N/A |
| 6/30/2023 | 125,944 | 22,406 | 27,812 | 53,675 | N/A |
| 3/31/2023 | 136,344 | 28,047 | 30,129 | 60,828 | N/A |
| 12/31/2022 | 140,489 | 29,619 | 28,619 | 61,082 | N/A |
| 9/30/2022 | 134,364 | 27,255 | 40,047 | 71,317 | N/A |
| 6/30/2022 | 125,055 | 22,908 | 33,993 | 63,774 | N/A |
| 3/31/2022 | 113,451 | 16,705 | 27,941 | 53,786 | N/A |
| 12/31/2021 | 104,563 | 13,222 | 19,302 | 42,957 | N/A |
| 9/30/2021 | 96,575 | 10,275 | 5,292 | 26,934 | N/A |
| 6/30/2021 | 91,469 | 7,656 | -1,306 | 18,265 | N/A |
| 3/31/2021 | 89,149 | 7,263 | 1,355 | 18,321 | N/A |
| 12/31/2020 | 87,893 | 5,462 | 3,360 | 18,164 | N/A |
| 9/30/2020 | 87,889 | 4,493 | -1,267 | 11,315 | N/A |
| 6/30/2020 | 87,799 | 4,159 | -296 | 11,840 | N/A |
| 3/31/2020 | 85,830 | 3,257 | 1,076 | 12,600 | N/A |
| 12/31/2019 | 82,536 | 3,260 | -1,090 | 10,277 | N/A |
| 9/30/2019 | 80,443 | 2,933 | 3,062 | 13,607 | N/A |
| 6/30/2019 | 78,881 | 2,653 | 4,947 | 14,479 | N/A |
| 3/31/2019 | 76,444 | 1,917 | 2,220 | 11,253 | N/A |
| 12/31/2018 | 75,733 | 1,705 | 4,565 | 13,535 | N/A |
| 9/30/2018 | 74,116 | 1,769 | 717 | 11,283 | N/A |
| 6/30/2018 | 69,674 | 465 | N/A | 7,365 | N/A |
| 3/31/2018 | 66,893 | 486 | N/A | 8,061 | N/A |
| 12/31/2017 | 64,993 | 414 | N/A | 5,698 | N/A |
| 9/30/2017 | 62,584 | 325 | N/A | 6,306 | N/A |
| 6/30/2017 | 61,502 | 347 | N/A | 7,724 | N/A |
| 3/31/2017 | 61,971 | 331 | N/A | 8,022 | N/A |
| 12/31/2016 | 62,638 | 12 | N/A | 8,925 | N/A |
| 9/30/2016 | 63,771 | 187 | N/A | 9,742 | N/A |
| 6/30/2016 | 65,304 | 645 | N/A | 10,301 | N/A |
| 3/31/2016 | 66,555 | 627 | N/A | 10,031 | N/A |
| 12/31/2015 | 64,650 | 288 | N/A | 10,243 | N/A |
| 9/30/2015 | 63,693 | -881 | N/A | 8,177 | N/A |
| 6/30/2015 | 62,778 | -615 | N/A | 7,293 | N/A |
| 3/31/2015 | 61,623 | -147 | N/A | 7,344 | N/A |
| 12/31/2014 | 61,755 | 497 | N/A | 6,623 | N/A |
| 9/30/2014 | 59,509 | 579 | N/A | 7,028 | N/A |
| 6/30/2014 | 58,754 | 562 | N/A | 6,864 | N/A |
| 3/31/2014 | 58,873 | 642 | N/A | 7,682 | N/A |
| 12/31/2013 | 59,935 | 1,173 | N/A | 9,002 | N/A |
Previsioni di crescita futura degli analisti
Guadagni vs tasso di risparmio: La crescita prevista degli utili di 3037 ( 62.5% all'anno) è superiore al tasso di risparmio ( 1.1% ).
Guadagni vs Mercato: Si prevede che gli utili di 3037 ( 62.5% all'anno) cresceranno più rapidamente del mercato TW ( 19.4% all'anno).
Guadagni ad alta crescita: Si prevede che gli utili di 3037 cresceranno in modo significativo nei prossimi 3 anni.
Ricavi vs Mercato: Si prevede che il fatturato di 3037 ( 19.7% all'anno) crescerà più rapidamente del mercato TW ( 12.7% all'anno).
Ricavi ad alta crescita: Si prevede che il fatturato di 3037 ( 19.7% all'anno) crescerà più lentamente di 20% all'anno.
Previsioni di crescita dell'utile per azione
Rendimento futuro del capitale proprio
ROE futuro: Si prevede che il Return on Equity di 3037 sarà elevato tra 3 anni ( 20.6 %)